Peripheral blood stem cell mobilization with Pegfilgrastim compared to Filgrastim in children and young adults with malignancies

Pediatric Blood and Cancer

Volumn 54, Issue 1, 2010, Pages 134-137

  Fritsch, Peter ^a   Schwinger, Wolfgang ^a   Schwantzer, Gerold ^a   Lackner, Herwig ^a   Sovinz, Petra ^a   Wendelin, Gerald ^a   Benesch, Martin ^a   Sipurzynski, Sabine ^a   Urban, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

CD34+ cell; Children; Malignancies; Pegfilgrastim; Peripheral stem cell collection

Indexed keywords

ANCESTIM; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; TOPOTECAN; UNCLASSIFIED DRUG; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RELAPSE; CD34 SELECTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPENDYMOMA; EWING SARCOMA; FEMALE; GERM CELL TUMOR; HUMAN; LEUKOCYTOSIS; LONG TERM CARE; MALE; MEDULLOBLASTOMA; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT CANCER; SCHOOL CHILD; SINGLE DRUG DOSE; STEM CELL MOBILIZATION; NEOPLASM; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73349092771     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22304     Document Type: Article

References (14)

1. Handgretinger R, Lang P, Ihm K, et al. Isolation and transplantation of highly purified autologous peripheralCD34(+) progenitor cells: Purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant 2002;29:731-736.
2. Arpaci F, Ataergin S, Ozet A, et al. The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: Results of a phase II study. Cancer 2005;104:1058-1065.
3. Wendelin G, Lackner H, Schwinger W, et al. Once-per-cycle Pegfilgrastim versus daily Filgrastim in pediatric patients with Ewing sarcoma. J Pediatr Hematol Oncol 2005;27:449-451.
4. Smith TJ, Khatcheressian J, Lyman GH, et al. Update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 2006; 24:3187-3205.
5. Bence AK, Adams VR. Pegfilgrastim: A new therapy to prevent neutropenic fever. J Am Pharm Assoc 2002;42:806-808.
6. Bruns I, Steidl U, Kronenwett R, et al.Asingle dose of 6 or 12mg of Pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma. Transfusion 2006;46:180-185.
7. Kroschinsky F, Holig K, Poppe-Thiede K, et al. Single-dose Pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica 2005;90:1665-1671.
8. Steidl U, Fenk R, Bruns I, et al. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 2005;35:33-36.
9. te Poele EM, Kamps WA, Tamminga RY, et al. Pegfilgrastim in pedaitric cancer patients. J Paediatr Hematol Oncol 2005;27:627-629.
10. Andre N, Kababri ME, Bertrand P, et al. Safety and efficacy of PegFilgrastim in children with cancer receing myelosuppressive chemotherapy. J Clin Oncol 2000;18:2522-2528.
11. Nosari A, Cairoli R, Ciapanna D, et al. Efficacy of single dose Pegfilgrastim in enhancing the mobilization of CD 34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone marrow Transplant 2006;38(6): 413-416.
12. Mijovic A, Russell N, Clark RE, et al. Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation. Bone Marrow Transplant 2005;35:1019. author reply 1020.
13. Cesaro S, Tridello G, Zanazzo AG, et al. PEG-Filgrastim for autologous peripheral CD 34+ stem cell collection in pediatric oncological patients; a phase II study. Blood 2008;112:806. (abstract 2312).
14. Kubista E, Glaspy J, Holmes FA, et al. On behalf of the Pegfilgrastim Study Group. Bone pain associated with once-per-cycle PegFilgrastim is similar to daily Filgrastim in patients with breast cancer. Clin Breast Cancer 2003;3:391-398.